Sun Pharmaceutical Industries Ltd. and the International Centre for Genetic Engineering and Biotechnology (ICGEB) have started a new collaboration to develop a vaccine targeted against all the four serotypes of the dengue virus; these plans supplement the duo's earlier alliance for a botanical drug targeting dengue.(Also see "Sun’s ‘Game Changing’ Dengue Drug May Launch In Four Years" - Scrip, 12 May, 2016.)
Sun Dips Toe Into Vaccines With Dengvaxia Challenge
India's top-ranked drug firm Sun Pharma is vying for a play in the dengue vaccines space via a collaboration with the non-profit research organization, International Centre for Genetic Engineering and Biotechnology. The partners expect their vaccine candidate to potentially best live-attenuated dengue vaccine candidates, including Sanofi's Dengvaxia.